Curcuma Longa ameliorates hemodynamic indices in patients with acute coronary syndrome

authors:

avatar Fateme Aleboye , avatar Monir Nobahar ORCID , * , avatar Raheb Ghorbani ORCID


how to cite: Aleboye F, Nobahar M, Ghorbani R. Curcuma Longa ameliorates hemodynamic indices in patients with acute coronary syndrome. koomesh. 2023;25(1):e152806. 

Abstract

Introduction: Acute coronary syndrome, the most common form of heart disease, is the main cause of disability and death. It impairs the hemodynamic indices, leading to endangering the patients' condition. Curcuma Longa modulates blood pressure, breathing parameters, and temperature. The present study aimed to investigate the possible protective effects of Curcuma Longa on hemodynamic indices in acute coronary syndrome patients. Materials and Methods: In this triple-blind clinical trial, 270 patients with acute coronary syndrome from the Coronary Care Unit in Kowsar Hospital in Semnan were included in the study from December 2019 to March 2021. Then, they were randomly divided into three groups, including the sham, intervention, and control groups (n=90). The intervention group received 500 mg of Curcuma Longa tablets. The sham group received 500 mg starch, Oisel, and lactose tablets. Drugs were administrated at 9 am, soon after breakfast, for 3 days. The control group received only the routine interventions. Before and 30 min after the intervention, the hemodynamic indices were recorded on 3 consecutive days using hemodynamic monitoring equipment (Pouyandegan Rah Saadat). Results: The average heart rate was significantly decreased in the intervention group than in the sham group (P=0.001 for day 1), (P<0.001 for day 2), and (P<0.001 for day 3). The average heart rate was significantly decreased in the intervention group than in the control group on the 2nd and 3rd days (P<0.001). Systolic and diastolic blood pressure were significantly decreased in the intervention group than in the sham, and control groups (P<0.001). Arterial blood oxygen saturation was significantly increased in the intervention group than in the sham and control groups (P<0.001). Conclusion: Curcuma Longa reduces pulse rate, as well as systolic and diastolic blood pressure, and enhances arterial blood oxygen saturation in a triple-blind clinical trial study. The protective effects of Curcuma Longa on hemodynamic indices may highlight the use of this simple and affordable intervention in Coronary Care Units.

References

  • 1.

    Li X, Lu Y, Sun Y, Zhang Q. Effect of curcumin on permeability of coronary artery and expression of related proteins in rat coronary atherosclerosis heart disease model. Int J Clin Exp Pathol 2015; 8: 7247-7253.

  • 2.

    Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med 2019; 22: 204-210.

  • 3.

    Jani M, Razm-Ara M, Safapoor M, Miralijani S, Miri F. The effect of education on quality of life in people with unstable angina. Cardiovasc Nurs J 2017; 5: 28-35.

  • 4.

    Yiadom MY. Emergency department treatment of acute coronary syndromes. Emerg Med Clin North Am 2011; 29: 699-710.

  • 5.

    Mohammadian B, Mohammadpour DA, Nematollahi DMR, Jamiati E. The effects of local heat therapy in the posterior part of chest on physiologic parameters in the patients with acute coronary syndrome: a randomized double-blind placebo-controlled clinical trial. Sci J Kurdistan Univ Med Sci 2017; 22: 72-81.

  • 6.

    Mohammad Pour A BMM, Saber N. The effect of rhythmic breathing on the cardiorespiratory parameters in acute coronary syndrome patients admitted admitted at CCU. J Sabzevar Univ Med Sci 2016; 23: 377-385. (Persian).

  • 7.

    Mohammad Aliha J, Najafi Ghezeljeh T, AghaHosseini F, Rahmani R. Effect of combined inhalation of Lavender oil, Chamomile and Neroli oil on vital signs of people with acute coronary syndrome. Cardiovasc Nurs J 2016; 5: 42-51.

  • 8.

    Abdi S, Oshvandi K, Karampourian A, Moghim beygi A, Homayoon far S. The effect of foot massage on blood pressure and heart rate of CCU patients. Nurs Midwifery J 2016; 14: 47-55.

  • 9.

    Asgari M, Soleimani M. Comprehensive book: critical care nursing in CCU, ICU and dialysis wards. 2020.

  • 10.

    Hosseini SH, Karamizadeh R, Sadeghi T, Esmaeili A. The effect of nitroglycerin spray and pearl on pain intensity and physiological indices of people with chest pain. Cardiovasc Nurs J 2017; 6: 48-55.

  • 11.

    Li Y, Zhang L, Lv S, Wang X, Zhang J, Tian X, et al. Efficacy and safety of oral Guanxinshutong capsules in patients with stable angina pectoris in China: a prospective, multicenter, double-blind, placebo-controlled, randomized clinical trial. BMC Complement Altern Med 2019; 19: 363.

  • 12.

    Sayari S, Nobahar M, Ghorbani R. Effect of foot reflexology massage on physiological indices in patients with acute myocardial infarction. Koomesh 2018; 20: 469-477. (Persian).

  • 13.

    Fallah Huseini H, Zahmatkash M, Haghighi M. A review on pharmacological effects of curcuma longa L. (Turmeric). J Med Plants 2010; 1.

  • 14.

    Habibi E, Esmaeeli H. A review of the effects of curcumin on histone acetyltransferase activity in the prevention of cardiac hypertrophy. J Babol Univ Med Sci 2017; 19: 27-35. (Persian).

  • 15.

    Rahman I, Biswas SK, Kirkham PA. Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 2006; 72: 1439-1452.

  • 16.

    Tirkey N, Kaur G, Vij G, Chopra K. Curcumin, a diferuloylmethane, attenuates cyclosporine-induced renal dysfunction and oxidative stress in rat kidneys. BMC Pharmacol 2005; 5: 1-10.

  • 17.

    Kilin E, Kaygisiz Z, Benek BS, Gmtekin K. Effects and mechanisms of curcumin on the hemodynamic variablesof isolated perfused rat hearts. Turk J Med Sci 2016; 46: 166-173.

  • 18.

    Jajvandian R. Turmeric from Traditional medicine point of view. Nurs Midwifery J 2004; 2.

  • 19.

    Adibian M, Hodaie H, Hedayati M, Sohrab G. Effect of curcumin supplementation on risk factors of cardiovascular disease in patient with type 2 diabetese. Res Med 2017; 41: 86-96.##https://doi.org/10.1530/endoabs.43.OC45.

  • 20.

    Pawar KS, Mastud RN, Pawar SK, Pawar SS, Bhoite RR, Bhoite RR, et al. Oral curcumin with piperine as adjuvant therapy for the treatment of COVID-19: A randomized clinical trial. Front Pharmacol 2021; 12: 669362.

  • 21.

    Park H, Lee JH, Sim JH, Park J, Choi SS, Leem JG. Effects of curcumin treatment in a diabetic neuropathic pain model of rats: involvement of c-Jun N-Terminal kinase located in the astrocytes and neurons of the dorsal root ganglion. Pain Res Manag 2021; 2021: 8787231.

  • 22.

    Flores M, de Batlle J. Central sleep apnoea is related to the severity and short-term prognosis of acute coronary syndrome. 2016; 11: e0167031.

  • 23.

    Haider S, Naqvi F, Tabassum S, Saleem S, Batool Z, Sadir S, et al. Preventive effects of curcumin against drug- and starvation-induced gastric erosions in rats. Sci Pharm 2013; 81: 549-558.

  • 24.

    Akazawa N, Choi Y, Miyaki A, Tanabe Y, Sugawara J, Ajisaka R, Maeda S. Effects of curcumin intake and aerobic exercise training on arterial compliance in postmenopausal women. Artery Res 2013; 7: 67-72.##https://doi.org/10.1016/j.artres.2012.09.003.

  • 25.

    Mirzabeigi P, Mohammadpour AH, Salarifar M, Gholami K, Mojtahedzadeh M, Javadi MR. The effect of curcumin on some of traditional and non-traditional cardiovascular risk factors: a pilot randomized, double-blind, placebo-controlled trial. Iran J Pharm Res 2015; 14: 479-486.

  • 26.

    Boarescu PM, Boarescu I, Bocan IC, Pop RM, Gheban D, Bulboac AE, et al. Curcumin nanoparticles protect against isoproterenol induced myocardial infarction by alleviating myocardial tissue oxidative stress, electrocardiogram, and biological changes. Molecules 2019; 24: 2802.

  • 27.

    Adaramoye OA, Anjos RM, Almeida MM, Veras RC, Silvia DF, Oliveira FA, et al. Hypotensive and endothelium-independent vasorelaxant effects of methanolic extract from Curcuma longa L. in rats. J Ethnopharmacology 2009; 124: 457-462.

  • 28.

    Alwi I, Santoso T, Suyono S, Sutrisna B, Suyatna FD, Kresno SB, Ernie S. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Med Indones 2008; 40: 201-210.

  • 29.

    Lee S, Jo C. Effect of co-administration of curcumin with amlodipine in hypertension. Nutrients 2021; 13.

  • 30.

    Hewlings SJ, Kalman DS. Curcumin: a review of its' effects on human health. Foods 2017; 6: 92.

  • 31.

    Kukongviriyapan U, Pannangpetch P, Kukongviriyapan V, Donpunha W, Sompamit K, Surawattanawan P. Curcumin protects against cadmium-induced vascular dysfunction, hypertension and tissue cadmium accumulation in mice. Nutrients 2014; 6: 1194-1208.

  • 32.

    Sahebkar A. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? Biofactors 2013; 39: 197-208.

  • 33.

    Jamil Q, Iqbal S, Jaeger W, Studenik C. Vasodilating, spasmolytic, inotropic and chronotropic activities of curcuminoids from Curcuma longa in isolated organ preparations of guinea pigs. J Physiol Pharmacol 2018; 69: 441-449.